Figs Inc

Figs Inc(FIGS)股票分析

$19.120

-0.411 (-2.15%)收盤時

Loading chart…
最高
20.310
開盤
19.880
成交量加權均價
19.36
成交量
5.29M
市值
890.29M
最低
18.660
成交金額
102.36M
企業價值/稅息折舊攤銷前利潤(TTM)
19.07

FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand. It designs and sells scrub wear and non-scrub wear, such as outerwear, under scrubs, footwear, compression socks, lab coats, lounge wear and other apparel. It markets and sells its products primarily in the United States. It designs all its products in-house, leverages third-party suppliers and manufacturers to produce its product components and finished products, and generally uses shallow initial buys and data-driven repurchasing decisions to test new products. It directly and actively coordinates with its suppliers at every step of its product development and production process to ensure that its quality standards are met. Its under scrubs include performance tops, and super-soft Pima cotton tops. Its outer layer products include footwear, lab coats and a variety of vests, jackets and fleeces. Its non-scrub wear product offerings include its lounge wear, which is its collection designed for off-shift moments.

AI 分析 of Figs Inc (FIGS)

買進

Figs Inc is a good buy right now due to its current price of $15.78, a strong RSI of 82.059 indicating overbought conditions, and a forward P/E ratio of 31.55 suggesting growth potential. The stock has shown impressive performance with a 1-year change of +122.57%, driven by strong earnings results, including a Q2 EPS of $0.15, which exceeded expectations by 57.14%. However, the main risk is the analyst downgrade from Telsey Advisory, lowering the price target to $16 due to macro uncertainties.

估值指標

Figs Inc(FIGS)目前預期本益比為 31.55,5 年平均預期本益比為 88.59。

預期本益比

低估
5 年均值 P/E
88.59
目前P/E
31.55
高估
124.05
低估
53.12

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
21.12
目前EV/EBITDA
19.07
高估
34.59
低估
7.65

預期股價營收比

合理
5 年均值 P/S
2.80
目前P/S
3.72
高估
4.81
低估
0.79

Alphio AI 對 FIGS 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%FIGS

$4.85

情境價格

基

基準

基準 · 50%FIGS

$4.52

情境價格

悲

悲觀

悲觀 · 25%FIGS

$4.18

情境價格

持有 FIGS 的大戶

B

Baron Capital Group, Inc.

+ 持有FIGS

+2.54%

3個月報酬率

D

Divisadero Street Capital Management, LP

+ 持有FIGS

-14.88%

3個月報酬率

事件時間軸

2026-10-12 (ET)

12:30:00

Figs Stock Rises 10.2% to $17.39

2026-08-06 (ET)

19:00:00

Stock Futures Mixed as Doximity Soars 83.93%

17:00:00

FIGS Reports Q2 Revenue of $196.6M, Beating Expectations

17:00:00

Raises FY26 Adjusted EBITDA Margin View to 14.8%-15%

2026-05-08 (ET)

12:10:00

Figs Shares Drop 28% to $11.06

資訊

FIGS 常見問題 —— 由 Alphio AI 解答

FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand. It designs and sells scrub wear and non-scrub wear, such as outerwear, under scrubs, footwear, compression socks, lab coats, lounge wear and other apparel. It markets and sells its products primarily in the United States. It designs all its products in-house, leverages third-party suppliers and manufacturers to produce its product components and finished products, and generally uses shallow initial buys and data-driven repurchasing decisions to test new products. It directly and actively coordinates with its suppliers at every step of its product development and production process to ensure that its quality standards are met. Its under scrubs include performance tops, and super-soft Pima cotton tops. Its outer layer products include footwear, lab coats and a variety of vests, jackets and fleeces. Its non-scrub wear product offerings include its lounge wear, which is its collection designed for off-shift moments. It operates in the Consumer Cyclicals sector (APPAREL & OTHER FINISHD PRODS OF FABRICS & SIMILAR industry).

Figs Inc is a good buy right now due to its current price of $15.78, a strong RSI of 82.059 indicating overbought conditions, and a forward P/E ratio of 31.55 suggesting growth potential. The stock has shown impressive performance with a 1-year change of +122.57%, driven by strong earnings results, including a Q2 EPS of $0.15, which exceeded expectations by 57.14%. However, the main risk is the analyst downgrade from Telsey Advisory, lowering the price target to $16 due to macro uncertainties.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易